IGFBP7 FOR DIAGNOSING DIASTOLIC DYSFUNCTION
    4.
    发明申请
    IGFBP7 FOR DIAGNOSING DIASTOLIC DYSFUNCTION 审中-公开
    IGFBP7用于诊断软组织损伤

    公开(公告)号:US20170010283A1

    公开(公告)日:2017-01-12

    申请号:US15274533

    申请日:2016-09-23

    CPC classification number: G01N33/6893 G01N33/6887 G01N2333/47 G01N2800/325

    Abstract: The present invention relates to a method for diagnosing and/or grading diastolic dysfunction or at least one structural or functional abnormality associated with diastolic dysfunction. The method comprises measuring the level of IGFBP7 (Insulin like growth factor binding protein 7) and, optionally, the level of at least one further marker in a patient suffering from heart failure, and comparing the level to a reference level. Further envisaged is a method of monitoring diastolic function in a patient suffering from heart failure. Also encompassed by the present invention are kits and devices adapted to carry out the method of the present invention.

    Abstract translation: 本发明涉及一种用于诊断和/或分级舒张功能障碍或与舒张功能障碍相关的至少一种结构或功能异常的方法。 该方法包括测量患有心力衰竭的患者中IGFBP7(胰岛素样生长因子结合蛋白7)的水平和任选地至少一个其他标记物的水平,并将该水平与参考水平进行比较。 进一步设想的是监测患有心力衰竭的患者的舒张功能的方法。 本发明还包括适用于实施本发明方法的试剂盒和装置。

Patent Agency Ranking